======= LRRTM3 =======
== Gene Information ==
* **Official Symbol**: LRRTM3
* **Official Name**: leucine rich repeat transmembrane neuronal 3
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=347731|347731]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q86VH5|Q86VH5]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=LRRTM3&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LRRTM3|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/610869|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Exhibits a limited synaptogenic activity in vitro, restricted to excitatory presynaptic differentiation (By similarity). May play a role in the development and maintenance of the vertebrate nervous system. {ECO:0000250}.
|LRRNT|
|LRR 4|
|positive regulation of amyloid-beta formation|
|positive regulation of amyloid precursor protein catabolic process|
|presynapse assembly|
|presynapse organization|
|regulation of amyloid-beta formation|
|regulation of amyloid precursor protein catabolic process|
|integral component of postsynaptic density membrane|
|positive regulation of synapse assembly|
|synapse assembly|
|regulation of synapse assembly|
|positive regulation of cellular amide metabolic process|
|regulation of synapse organization|
|regulation of synapse structure or activity|
|extracellular matrix|
|synapse organization|
|glutamatergic synapse|
|regulation of cellular amide metabolic process|
|positive regulation of cellular component biogenesis|
|positive regulation of nervous system development|
|cell junction|
|regulation of nervous system development|
|regulation of cellular component biogenesis|
|positive regulation of cellular component organization|
|positive regulation of developmental process|
|extracellular space|
|positive regulation of protein metabolic process|
|positive regulation of multicellular organismal process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|-1.78|
|[[:results:exp300|VE-822 0.04μM R06 exp300]]|1.73|
|[[:results:exp314|Dimethyloxaloylglycine 11μM R07 exp314]]|1.77|
|[[:results:exp341|BRD2 inhibitor II 20μM R07 exp341]]|1.86|
|[[:results:exp391|Pomalidomide 20μM R07 exp391]]|1.96|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 4736
* **Expression level (log2 read counts)**: -5.01
{{:chemogenomics:nalm6 dist.png?nolink |}}